EA201792566A1 - Замещенные фенилоксазолидиноны для антимикробной терапии - Google Patents
Замещенные фенилоксазолидиноны для антимикробной терапииInfo
- Publication number
- EA201792566A1 EA201792566A1 EA201792566A EA201792566A EA201792566A1 EA 201792566 A1 EA201792566 A1 EA 201792566A1 EA 201792566 A EA201792566 A EA 201792566A EA 201792566 A EA201792566 A EA 201792566A EA 201792566 A1 EA201792566 A1 EA 201792566A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- phylenoxazozolidinones
- substituted
- antimicrobial therapy
- spirocyclic
- bicyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Настоящее изобретение относится к новым оксазолидинонам:или их фармацевтически приемлемым солям, содержащим кольцо A, характеризующееся N-содержащими моноциклическими, бициклическими или спироциклическими заместителями, к их получению и их применению в качестве лекарственных средств для лечения Mycobacterium tuberculosis и других микробных инфекций, отдельно или в комбинации с другими противоинфекционными средствами лечения.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562193963P | 2015-07-17 | 2015-07-17 | |
PCT/US2016/042486 WO2017015106A1 (en) | 2015-07-17 | 2016-07-15 | Substituted phenyloxazolidinones for antimicrobial therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201792566A1 true EA201792566A1 (ru) | 2018-10-31 |
EA037643B1 EA037643B1 (ru) | 2021-04-26 |
Family
ID=57834866
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201792566A EA037643B1 (ru) | 2015-07-17 | 2016-07-15 | Замещенные фенилоксазолидиноны для антимикробной терапии |
EA202190167A EA202190167A1 (ru) | 2015-07-17 | 2016-07-15 | Замещенные фенилоксазолидиноны для антимикробной терапии |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202190167A EA202190167A1 (ru) | 2015-07-17 | 2016-07-15 | Замещенные фенилоксазолидиноны для антимикробной терапии |
Country Status (13)
Country | Link |
---|---|
US (2) | US10550092B2 (ru) |
EP (2) | EP3932917A3 (ru) |
JP (4) | JP6786598B2 (ru) |
KR (1) | KR102511898B1 (ru) |
CN (2) | CN113603683B (ru) |
AU (3) | AU2016295165B2 (ru) |
BR (1) | BR112018000991A2 (ru) |
CA (1) | CA2990260A1 (ru) |
EA (2) | EA037643B1 (ru) |
ES (1) | ES2897973T3 (ru) |
HK (1) | HK1255105A1 (ru) |
WO (1) | WO2017015106A1 (ru) |
ZA (1) | ZA201800189B (ru) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113603683B (zh) * | 2015-07-17 | 2024-06-14 | 结核病药物开发全球联盟公司 | 用于抗微生物治疗的经取代苯基噁唑烷酮 |
CN108727406B (zh) * | 2017-03-28 | 2021-12-07 | 北京协和制药二厂 | 含氮杂环取代的苯并噁嗪噁唑烷酮类化合物及其制备方法和用途 |
US20210267953A1 (en) | 2018-07-25 | 2021-09-02 | Cadila Healthcare Limited | Substituted oxazolidinones for the treatment of mammalian infections |
EP3914587A4 (en) * | 2019-01-18 | 2022-11-23 | Merck Sharp & Dohme LLC | OXAZOLIDINONE COMPOUNDS AND USES THEREOF AS ANTIBACTERIAL AGENTS |
WO2020234636A1 (en) | 2019-05-17 | 2020-11-26 | Cadila Healthcare Limited | Novel compounds for the treatment of mammalian infections |
CN110922411B (zh) * | 2019-11-27 | 2021-06-04 | 合肥远志医药科技开发有限公司 | 一种药物中间体的合成方法 |
WO2021184339A1 (en) * | 2020-03-20 | 2021-09-23 | Merck Sharp & Dohme Corp. | Oxazolidinone compound and methods of use thereof as an antibacterial agent |
CN113999152B (zh) * | 2021-07-14 | 2023-05-09 | 上海凌富药物研究有限公司 | 一种顺式-1-苄基-2,4-二烷氧基羰基氮杂环丁烷的合成方法 |
WO2024035618A1 (en) * | 2022-08-10 | 2024-02-15 | Merck Sharp & Dohme Llc | Processes for preparing oxazolidinone compounds |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY115155A (en) * | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
CN1046520C (zh) * | 1994-11-15 | 1999-11-17 | 法玛西雅厄普约翰美国公司 | 二环噁嗪及噻嗪噁唑烷酮抗菌剂 |
DE69614847T2 (de) * | 1995-05-11 | 2002-04-04 | Upjohn Co | Spirocyclische und bicyclische diazinyl- und carbazinyloxazolidinone |
US6255304B1 (en) * | 1997-05-30 | 2001-07-03 | Pharmacia & Upjohn Company | Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
WO2000032599A1 (en) * | 1998-11-27 | 2000-06-08 | Pharmacia & Upjohn Company | Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
EP1451164A2 (en) * | 2001-07-12 | 2004-09-01 | PHARMACIA & UPJOHN COMPANY | Amide derivatives having improved solubility |
PL372191A1 (en) | 2002-02-28 | 2005-07-11 | Astrazeneca Ab | 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents |
WO2003093247A2 (en) * | 2002-04-30 | 2003-11-13 | Orchid Chemicals & Pharmaceuticals Ltd | Antibacterial agents |
TW200403240A (en) * | 2002-06-28 | 2004-03-01 | Upjohn Co | Difluorothioacetamides of oxazolidinones as antibacterial agents |
US6875784B2 (en) * | 2002-10-09 | 2005-04-05 | Pharmacia & Upjohn Company | Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives |
CN1237056C (zh) * | 2002-12-25 | 2006-01-18 | 中国科学院上海药物研究所 | 噁唑烷酮类化合物、其制备方法和用途 |
CA2536480A1 (en) * | 2003-08-25 | 2005-03-03 | Warner-Lambert Company Llc | Novel antimicrobial aryloxazolidinone compounds |
EP1819702A1 (en) | 2004-11-29 | 2007-08-22 | Pharmacia & Upjohn Company LLC | Thiazepine oxazolidinones as antibacterial agents |
CA2607660A1 (en) * | 2005-05-06 | 2006-11-16 | University Of South Florida | N-thiolated 2-oxazolidone antibiotics |
EP1899331B1 (en) * | 2005-06-29 | 2009-11-25 | Pharmacia & Upjohn Company LLC | Homomorpholine oxazolidinones as antibacterial agents |
WO2007004037A1 (en) | 2005-07-06 | 2007-01-11 | Pharmacia & Upjohn Company Llc | Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents |
US7666864B2 (en) * | 2008-03-26 | 2010-02-23 | Global Alliance For Tb Drug Development | Bicyclic nitroimidazole-substituted phenyl oxazolidinones |
KR100980681B1 (ko) * | 2008-09-16 | 2010-09-07 | 한국과학기술연구원 | 디플루오로페닐 유도체를 갖는 신규한 옥사졸리디논 유도체또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 하는 항생제 조성물 |
US20110053916A1 (en) * | 2009-08-14 | 2011-03-03 | Vertex Pharmaceuticals Incorporated | Pyrimidine compounds as tuberculosis inhibitors |
CN113603683B (zh) * | 2015-07-17 | 2024-06-14 | 结核病药物开发全球联盟公司 | 用于抗微生物治疗的经取代苯基噁唑烷酮 |
-
2016
- 2016-07-15 CN CN202111073361.5A patent/CN113603683B/zh active Active
- 2016-07-15 CA CA2990260A patent/CA2990260A1/en active Pending
- 2016-07-15 AU AU2016295165A patent/AU2016295165B2/en active Active
- 2016-07-15 JP JP2018521488A patent/JP6786598B2/ja active Active
- 2016-07-15 WO PCT/US2016/042486 patent/WO2017015106A1/en active Application Filing
- 2016-07-15 US US15/738,503 patent/US10550092B2/en active Active
- 2016-07-15 BR BR112018000991A patent/BR112018000991A2/pt not_active Application Discontinuation
- 2016-07-15 EA EA201792566A patent/EA037643B1/ru unknown
- 2016-07-15 CN CN201680054227.1A patent/CN108348507B/zh active Active
- 2016-07-15 KR KR1020187003093A patent/KR102511898B1/ko active IP Right Grant
- 2016-07-15 EP EP21185896.4A patent/EP3932917A3/en active Pending
- 2016-07-15 EA EA202190167A patent/EA202190167A1/ru unknown
- 2016-07-15 EP EP16828300.0A patent/EP3307268B1/en active Active
- 2016-07-15 ES ES16828300T patent/ES2897973T3/es active Active
-
2018
- 2018-01-10 ZA ZA2018/00189A patent/ZA201800189B/en unknown
- 2018-11-08 HK HK18114260.4A patent/HK1255105A1/zh unknown
-
2020
- 2020-01-13 US US16/740,660 patent/US11964949B2/en active Active
- 2020-05-18 JP JP2020086709A patent/JP7232212B2/ja active Active
-
2021
- 2021-07-16 AU AU2021205116A patent/AU2021205116B2/en active Active
- 2021-09-02 JP JP2021143166A patent/JP2021183647A/ja not_active Withdrawn
-
2022
- 2022-11-11 AU AU2022268387A patent/AU2022268387A1/en not_active Abandoned
-
2023
- 2023-08-04 JP JP2023127905A patent/JP2023133610A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201792566A1 (ru) | Замещенные фенилоксазолидиноны для антимикробной терапии | |
EA201790766A1 (ru) | Новые соединения метилпиперидина, подходящие для ингибирования микросомальной простагландин-e2-синтазы 1 | |
MX2017000408A (es) | Compuestos antiproliferativos y métodos de uso de los mismos. | |
EA201791069A1 (ru) | Комбинированная терапия для лечения устойчивых бактериальных инфекций | |
AR103680A1 (es) | Inhibidores selectivos de bace1 | |
EA201591362A1 (ru) | Соединения и способы лечения бактериальных инфекций | |
PH12016502352A1 (en) | Pharmaceutical composition | |
NZ713946A (en) | Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections | |
EA201790726A1 (ru) | Фармацевтическая композиция для лечения язвенного колита | |
TW201613578A (en) | Pharmaceutical combinations | |
PH12016501988A1 (en) | Antibacterial compounds | |
EA201691918A1 (ru) | Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения | |
BR112017004580A2 (pt) | composto, composição farmacêutica, produto de combinação, uso de um composto ou sal farmaceuticamente aceitável, e, método de tratamento. | |
EA201890614A1 (ru) | Комбинированная антибактериальная композиция и короткий курс антибактериальной терапии | |
EA201790464A1 (ru) | Гетеробициклические соединения и их применение для лечения туберкулеза | |
MX2022006229A (es) | Composiciones y metodos para el tratamiento de resistencia a la insulina. | |
EA201692111A1 (ru) | Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний | |
ZA202200511B (en) | Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of tuberculosis | |
EA201890412A1 (ru) | АНТИБАКТЕРИАЛЬНЫЕ АГЕНТЫ, СОДЕРЖАЩИЕ ПИРАЗИНО[2,3-b][1,4]ОКСАЗИН-3-ОН ИЛИ РОДСТВЕННУЮ КОЛЬЦЕВУЮ СИСТЕМУ | |
EA201891008A3 (ru) | Лечение симптомов, связанных с андроген-депривационной терапией | |
TR201908936T4 (tr) | Opioidler ile kombinasyon halinde palmitoiletanolamid kullanımı. | |
EA201501130A1 (ru) | Офтальмологическая фармацевтическая композиция | |
TR201908937T4 (tr) | P38 MAP kinazı inhibe eden indanil üre bileşikleri. | |
EA201790020A1 (ru) | Соединения, фармацевтические композиции и их применение при лечении нейродегенеративных заболеваний | |
EA201692164A1 (ru) | Лекарственное средство для лечения пациентов с тиннитусом |